Author:
Silva Natalia Ingrid Oliveira,Sacchetto Lívia,de Rezende Izabela Maurício,Trindade Giliane de Souza,LaBeaud Angelle Desiree,de Thoisy Benoit,Drumond Betânia Paiva
Abstract
AbstractYellow fever (YF) is an acute viral disease, affecting humans and non-human primates (NHP), caused by the yellow fever virus (YFV). Despite the existence of a safe vaccine, YF continues to cause morbidity and mortality in thousands of people in Africa and South America. Since 2016, massive YF outbreaks have taken place in Brazil, reaching YF–free zones, causing thousands of deaths of humans and NHP. Here we reviewed the main epidemiological aspects, new clinical findings in humans, and issues regarding YFV infection in vectors and NHP in Brazil. The 2016–2019 YF epidemics have been considered the most significant outbreaks of the last 70 years in the country, and the number of human cases was 2.8 times higher than total cases in the previous 36 years. A new YFV lineage was associated with the recent outbreaks, with persistent circulation in Southeast Brazil until 2019. Due to the high number of infected patients, it was possible to evaluate severity and death predictors and new clinical features of YF. Haemagogus janthinomys and Haemagogus leucocelaenus were considered the primary vectors during the outbreaks, and no human case suggested the occurrence of the urban transmission cycle. YFV was detected in a variety of NHP specimens presenting viscerotropic disease, similar to that described experimentally. Further studies regarding NHP sensitivity to YFV, YF pathogenesis, and the duration of the immune response in NHP could contribute to YF surveillance, control, and future strategies for NHP conservation.
Funder
Fundação de Amparo à Pesquisa do Estado de Minas Gerais
Decit/SCTIE/MoH
SES-MG/SEPLAG-MG/FIOCRUZ/FAPEMIG
ERDF/FEDER
Assistance from Collectivité Territoriale de la Guyane and Direction Régionale pour la Recherche et la Technologie, and the Laboratoire d’Excellence CEBA “Investissement d’Avenir”
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Conselho Nacional de Desenvolvimento Científico e Tecnológico
National Council for Scientific and Technological Development
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Virology
Reference143 articles.
1. Monath TP. Yellow fever: an update. Lancet Infect Dis. 2001;1:11–20.
2. Vasconcelos PFC. Yellow fever. Rev Soc Bras Med Trop. 2003;36:275–93.
3. Maguire HCF, Heymann DL. Yellow fever in Africa. BMJ. 2016:i3764.
4. MS-BR. Centro de Operações de emergências em Saúde Pública sobre Febre Amarela – No 43/2017 [Internet]. Ministério da Saúde do Bras. 2017:1–7. Available from: http://portalarquivos.saude.gov.br/images/pdf/2017/junho/02/COES-FEBRE-AMARELA%2D%2D-INFORME-43%2D%2D-Atualiza%2D%2D%2D%2Do-em-31maio2017.pdf [cited 2019 Aug 1]
5. MS-BR. Monitoramento do Período Sazonal da Febre Amarela Brasil – 2017/2018 - informe no 27 | 2017/2018 [Internet]. Ministério da Saúde do Bras. 2018:1–24. Available from: http://portalarquivos2.saude.gov.br/images/pdf/2018/outubro/08/Informe-FA.pdf [cited 2019 Jul 5]
Cited by
120 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献